Terapia Génica del Cáncer
TGC
Sheba Medical Center
Ramat Gan, IsraelPublicaciones en colaboración con investigadores/as de Sheba Medical Center (1)
2016
-
SIRFLOX: Randomized phase III trial comparing first-line mFOLFOX6 (Plus or Minus Bevacizumab) versus mFOLFOX6 (Plus or Minus Bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer
Journal of Clinical Oncology, Vol. 34, Núm. 15, pp. 1723-1731